MARIDITH HOLLIS: Open Payments
NPI 1730612086 · DAPHNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,726 in 57 payments from 9 companies in 2025. Trend: 2023 $613 · 2024 $789 · 2025 $14,726
Speaker / faculty: $10,830Food & beverage: $1,638Consulting: $1,600Travel & lodging: $546Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 25 | $13,551 |
| E.R. Squibb & Sons, L.L.C. | 14 | $373 |
| Vanda Pharmaceuticals Inc. | 3 | $169 |
| Indivior Inc. | 3 | $163 |
| Teva Pharmaceuticals USA, Inc. | 5 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $147 |
| Otsuka America Pharmaceutical, Inc. | 2 | $103 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Lundbeck LLC | 1 | $16 |
Products named: LYBALVI, COBENFY, ARISTADA, FANAPT, SUBLOCADE, CAPLYTA, REXULTI, VIVITROL.
Industry payments across AL — which companies pay providers there.
